Last reviewed · How we verify

NCT06873958

Reducing Pneumonia with LMA in Lung Wedge Resection

Not yet recruiting Last updated 13 March 2025
What this trial tests

trial in Pneumonia, Postoperative in 700 participants. Not yet recruiting.

Timeline
15 March 2025
Primary endpoint
30 March 2025
30 April 2025

Quick facts

Lead sponsorHai Feng
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment700
Start date15 March 2025
Primary completion30 March 2025
Estimated completion30 April 2025
Sites1 location across China

Conditions studied

Sponsor

Hai Feng

Who can join

18 and older, any sex, with Pneumonia, Postoperative or Anesthesia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This retrospective cohort study aims to evaluate whether spontaneous breathing laryngeal mask anesthesia (LMA-SBA) reduces the incidence of postoperative pneumonia compared to single-lung isolation mechanical ventilation in patients undergoing thoracoscopic wedge resection. Using propensity score overlap weighting, we will adjust for multiple confounders, including age, COPD, surgical duration, and preoperative laboratory values. Secondary outcomes include postoperative recovery time, fever severity, white blood cell count, neutrophil percentage, length of hospital stay, and ICU admission rate. The study has been approved by the Ethics Committee of the First Affiliated Hospital of Shandong First Medical University (Approval No. YXLL-KY-2025(037)).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06873958.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing